메뉴 건너뛰기




Volumn 6, Issue 4, 2014, Pages 276-287

Epidermal permeability barrier defects and barrier repair therapy in atopic dermatitis

Author keywords

Atopic dermatitis; Barrier repair therapy; Skin barrier

Indexed keywords

ANTIINFLAMMATORY AGENT; CERAMIDE; CLAUDIN 1; CLAUDIN 4; FILAGGRIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; POLYPEPTIDE ANTIBIOTIC AGENT; PROTEINASE ACTIVATED RECEPTOR 2; THYMIC STROMAL LYMPHOPOIETIN;

EID: 84903446483     PISSN: 20927355     EISSN: 20927363     Source Type: Journal    
DOI: 10.4168/aair.2014.6.4.276     Document Type: Article
Times cited : (92)

References (100)
  • 1
    • 84856536446 scopus 로고    scopus 로고
    • Epidermal barrier dysfunction and cutaneous sensitization in atopic diseases
    • Kubo A, Nagao K, Amagai M. Epidermal barrier dysfunction and cutaneous sensitization in atopic diseases. J Clin Invest 2012;122:440-7.
    • (2012) J Clin Invest , vol.122 , pp. 440-447
    • Kubo, A.1    Nagao, K.2    Amagai, M.3
  • 2
    • 78650274430 scopus 로고    scopus 로고
    • Eczema prevalence in the United States: data from the 2003 National Survey of Children's Health
    • Shaw TE, Currie GP, Koudelka CW, Simpson EL. Eczema prevalence in the United States: data from the 2003 National Survey of Children's Health. J Invest Dermatol 2011;131:67-73.
    • (2011) J Invest Dermatol , vol.131 , pp. 67-73
    • Shaw, T.E.1    Currie, G.P.2    Koudelka, C.W.3    Simpson, E.L.4
  • 3
    • 0035725896 scopus 로고    scopus 로고
    • Trends in the prevalence of atopic dermatitis in school children: longitudinal study in Osaka Prefecture, Japan, from 1985 to 1997
    • Yura A, Shimizu T. Trends in the prevalence of atopic dermatitis in school children: longitudinal study in Osaka Prefecture, Japan, from 1985 to 1997. Br J Dermatol 2001;145:966-73.
    • (2001) Br J Dermatol , vol.145 , pp. 966-973
    • Yura, A.1    Shimizu, T.2
  • 4
    • 18844441676 scopus 로고    scopus 로고
    • Stable incidence of atopic dermatitis among children in Denmark during the 1990s
    • Olesen AB, Bang K, Juul S, Thestrup-Pedersen K. Stable incidence of atopic dermatitis among children in Denmark during the 1990s. Acta Derm Venereol 2005;85:244-7.
    • (2005) Acta Derm Venereol , vol.85 , pp. 244-247
    • Olesen, A.B.1    Bang, K.2    Juul, S.3    Thestrup-Pedersen, K.4
  • 5
    • 77957895641 scopus 로고    scopus 로고
    • Therapeutic implications of a barrier-based pathogenesis of atopic dermatitis
    • Elias PM. Therapeutic implications of a barrier-based pathogenesis of atopic dermatitis. Ann Dermatol 2010;22:245-54.
    • (2010) Ann Dermatol , vol.22 , pp. 245-254
    • Elias, P.M.1
  • 6
    • 84873333462 scopus 로고    scopus 로고
    • The multifunctional role of filaggrin in allergic skin disease
    • McAleer MA, Irvine AD. The multifunctional role of filaggrin in allergic skin disease. J Allergy Clin Immunol 2013;131:280-91.
    • (2013) J Allergy Clin Immunol , vol.131 , pp. 280-291
    • McAleer, M.A.1    Irvine, A.D.2
  • 7
    • 84873354913 scopus 로고    scopus 로고
    • The cutaneous innate immune response in patients with atopic dermatitis
    • Kuo IH, Yoshida T, De Benedetto A, Beck LA. The cutaneous innate immune response in patients with atopic dermatitis. J Allergy Clin Immunol 2013;131:266-78.
    • (2013) J Allergy Clin Immunol , vol.131 , pp. 266-278
    • Kuo, I.H.1    Yoshida, T.2    De Benedetto, A.3    Beck, L.A.4
  • 8
    • 33745586518 scopus 로고    scopus 로고
    • An update of the defensive barrier function of skin
    • Lee SH, Jeong SK, Ahn SK. An update of the defensive barrier function of skin. Yonsei Med J 2006;47:293-306.
    • (2006) Yonsei Med J , vol.47 , pp. 293-306
    • Lee, S.H.1    Jeong, S.K.2    Ahn, S.K.3
  • 9
    • 84886739838 scopus 로고    scopus 로고
    • Atopic dermatitis and the stratum corneum: part 1: the role of filaggrin in the stratum corneum barrier and atopic skin
    • Levin J, Friedlander SF, Del Rosso JQ. Atopic dermatitis and the stratum corneum: part 1: the role of filaggrin in the stratum corneum barrier and atopic skin. J Clin Aesthet Dermatol 2013;6:16-22.
    • (2013) J Clin Aesthet Dermatol , vol.6 , pp. 16-22
    • Levin, J.1    Friedlander, S.F.2    Del Rosso, J.Q.3
  • 10
    • 67649838095 scopus 로고    scopus 로고
    • Filaggrin in the frontline: role in skin barrier function and disease
    • Sandilands A, Sutherland C, Irvine AD, McLean WH. Filaggrin in the frontline: role in skin barrier function and disease. J Cell Sci 2009;122:1285-94.
    • (2009) J Cell Sci , vol.122 , pp. 1285-1294
    • Sandilands, A.1    Sutherland, C.2    Irvine, A.D.3    McLean, W.H.4
  • 13
    • 77957938941 scopus 로고    scopus 로고
    • Protease and protease-activated receptor-2 signaling in the pathogenesis of atopic dermatitis
    • Lee SE, Jeong SK, Lee SH. Protease and protease-activated receptor-2 signaling in the pathogenesis of atopic dermatitis. Yonsei Med J 2010;51:808-22.
    • (2010) Yonsei Med J , vol.51 , pp. 808-822
    • Lee, S.E.1    Jeong, S.K.2    Lee, S.H.3
  • 16
    • 84878656041 scopus 로고    scopus 로고
    • Ichthyosis vulgaris: the filaggrin mutation disease
    • Thyssen JP, Godoy-Gijon E, Elias PM. Ichthyosis vulgaris: the filaggrin mutation disease. Br J Dermatol 2013;168:1155-66.
    • (2013) Br J Dermatol , vol.168 , pp. 1155-1166
    • Thyssen, J.P.1    Godoy-Gijon, E.2    Elias, P.M.3
  • 20
    • 84887025956 scopus 로고    scopus 로고
    • A homozygous nonsense mutation in the gene for Tmem79, a component for the lamellar granule secretory system, produces spontaneous eczema in an experimental model of atopic dermatitis
    • 1111-20.e4
    • Sasaki T, Shiohama A, Kubo A, Kawasaki H, Ishida-Yamamoto A, Yamada T, Hachiya T, Shimizu A, Okano H, Kudoh J, Amagai M. A homozygous nonsense mutation in the gene for Tmem79, a component for the lamellar granule secretory system, produces spontaneous eczema in an experimental model of atopic dermatitis. J Allergy Clin Immunol 2013;132:1111-20.e4.
    • (2013) J Allergy Clin Immunol , vol.132
    • Sasaki, T.1    Shiohama, A.2    Kubo, A.3    Kawasaki, H.4    Ishida-Yamamoto, A.5    Yamada, T.6    Hachiya, T.7    Shimizu, A.8    Okano, H.9    Kudoh, J.10    Amagai, M.11
  • 22
    • 84887823825 scopus 로고    scopus 로고
    • IL-25 enhances HSV-1 replication by inhibiting filaggrin expression, and acts synergistically with Th2 cytokines to enhance HSV-1 replication
    • Kim BE, Bin L, Ye YM, Ramamoorthy P, Leung DY. IL-25 enhances HSV-1 replication by inhibiting filaggrin expression, and acts synergistically with Th2 cytokines to enhance HSV-1 replication. J Invest Dermatol 2013;133:2678-85.
    • (2013) J Invest Dermatol , vol.133 , pp. 2678-2685
    • Kim, B.E.1    Bin, L.2    Ye, Y.M.3    Ramamoorthy, P.4    Leung, D.Y.5
  • 23
    • 84873249337 scopus 로고    scopus 로고
    • Acute modulations in stratum corneum permeability barrier function affect claudin expression and epidermal tight junction function via changes of epidermal calcium gradient
    • Baek JH, Lee SE, Choi KJ, Choi EH, Lee SH. Acute modulations in stratum corneum permeability barrier function affect claudin expression and epidermal tight junction function via changes of epidermal calcium gradient. Yonsei Med J 2013;54:523-8.
    • (2013) Yonsei Med J , vol.54 , pp. 523-528
    • Baek, J.H.1    Lee, S.E.2    Choi, K.J.3    Choi, E.H.4    Lee, S.H.5
  • 24
    • 84875808184 scopus 로고    scopus 로고
    • Tight junction dysfunction in the stratum granulosum leads to aberrant stratum corneum barrier function in claudin-1-deficient mice
    • Sugawara T, Iwamoto N, Akashi M, Kojima T, Hisatsune J, Sugai M, Furuse M. Tight junction dysfunction in the stratum granulosum leads to aberrant stratum corneum barrier function in claudin-1-deficient mice. J Dermatol Sci 2013;70:12-8.
    • (2013) J Dermatol Sci , vol.70 , pp. 12-18
    • Sugawara, T.1    Iwamoto, N.2    Akashi, M.3    Kojima, T.4    Hisatsune, J.5    Sugai, M.6    Furuse, M.7
  • 25
    • 73949120263 scopus 로고    scopus 로고
    • External antigen uptake by Langerhans cells with reorganization of epidermal tight junction barriers
    • Kubo A, Nagao K, Yokouchi M, Sasaki H, Amagai M. External antigen uptake by Langerhans cells with reorganization of epidermal tight junction barriers. J Exp Med 2009;206:2937-46.
    • (2009) J Exp Med , vol.206 , pp. 2937-2946
    • Kubo, A.1    Nagao, K.2    Yokouchi, M.3    Sasaki, H.4    Amagai, M.5
  • 27
    • 84873569974 scopus 로고    scopus 로고
    • Impaired tight junctions obstruct stratum corneum formation by altering polar lipid and profilaggrin processing
    • Yuki T, Komiya A, Kusaka A, Kuze T, Sugiyama Y, Inoue S. Impaired tight junctions obstruct stratum corneum formation by altering polar lipid and profilaggrin processing. J Dermatol Sci 2013;69:148-58.
    • (2013) J Dermatol Sci , vol.69 , pp. 148-158
    • Yuki, T.1    Komiya, A.2    Kusaka, A.3    Kuze, T.4    Sugiyama, Y.5    Inoue, S.6
  • 30
    • 4344659169 scopus 로고    scopus 로고
    • Stratum corneum pH in atopic dermatitis: impact on skin barrier function and colonization with Staphylococcus Aureus
    • Rippke F, Schreiner V, Doering T, Maibach HI. Stratum corneum pH in atopic dermatitis: impact on skin barrier function and colonization with Staphylococcus Aureus. Am J Clin Dermatol 2004;5:217-23.
    • (2004) Am J Clin Dermatol , vol.5 , pp. 217-223
    • Rippke, F.1    Schreiner, V.2    Doering, T.3    Maibach, H.I.4
  • 33
    • 58849157836 scopus 로고    scopus 로고
    • Proteinase-activated receptor-2 in the skin: receptor expression, activation and function during health and disease
    • Rattenholl A, Steinhoff M. Proteinase-activated receptor-2 in the skin: receptor expression, activation and function during health and disease. Drug News Perspect 2008;21:369-81.
    • (2008) Drug News Perspect , vol.21 , pp. 369-381
    • Rattenholl, A.1    Steinhoff, M.2
  • 35
    • 78149464736 scopus 로고    scopus 로고
    • Par2 inactivation inhibits early production of TSLP, but not cutaneous inflammation, in Netherton syndrome adult mouse model
    • Briot A, Lacroix M, Robin A, Steinhoff M, Deraison C, Hovnanian A. Par2 inactivation inhibits early production of TSLP, but not cutaneous inflammation, in Netherton syndrome adult mouse model. J Invest Dermatol 2010;130:2736-42.
    • (2010) J Invest Dermatol , vol.130 , pp. 2736-2742
    • Briot, A.1    Lacroix, M.2    Robin, A.3    Steinhoff, M.4    Deraison, C.5    Hovnanian, A.6
  • 38
    • 0038579516 scopus 로고    scopus 로고
    • Association of SPINK5 gene polymorphisms with atopic dermatitis in the Japanese population
    • Kato A, Fukai K, Oiso N, Hosomi N, Murakami T, Ishii M. Association of SPINK5 gene polymorphisms with atopic dermatitis in the Japanese population. Br J Dermatol 2003;148:665-9.
    • (2003) Br J Dermatol , vol.148 , pp. 665-669
    • Kato, A.1    Fukai, K.2    Oiso, N.3    Hosomi, N.4    Murakami, T.5    Ishii, M.6
  • 39
    • 34247238705 scopus 로고    scopus 로고
    • A nonsynonymous substitution of cystatin A, a cysteine protease inhibitor of house dust mite protease, leads to decreased mRNA stability and shows a significant association with atopic dermatitis
    • Vasilopoulos Y, Cork MJ, Teare D, Marinou I, Ward SJ, Duff GW, Tazi-Ahnini R. A nonsynonymous substitution of cystatin A, a cysteine protease inhibitor of house dust mite protease, leads to decreased mRNA stability and shows a significant association with atopic dermatitis. Allergy 2007;62:514-9.
    • (2007) Allergy , vol.62 , pp. 514-519
    • Vasilopoulos, Y.1    Cork, M.J.2    Teare, D.3    Marinou, I.4    Ward, S.J.5    Duff, G.W.6    Tazi-Ahnini, R.7
  • 40
    • 47349085166 scopus 로고    scopus 로고
    • Proteolytically active allergens cause barrier breakdown
    • Roelandt T, Heughebaert C, Hachem JP. Proteolytically active allergens cause barrier breakdown. J Invest Dermatol 2008;128:1878-80.
    • (2008) J Invest Dermatol , vol.128 , pp. 1878-1880
    • Roelandt, T.1    Heughebaert, C.2    Hachem, J.P.3
  • 43
    • 80054026326 scopus 로고    scopus 로고
    • Peroxisome proliferator-activated receptors (PPARs) in dermatology: Challenge and promise
    • Sertznig P, Reichrath J. Peroxisome proliferator-activated receptors (PPARs) in dermatology: Challenge and promise. Dermatoendocrinol 2011;3:130-5.
    • (2011) Dermatoendocrinol , vol.3 , pp. 130-135
    • Sertznig, P.1    Reichrath, J.2
  • 44
    • 73149125138 scopus 로고    scopus 로고
    • Murine atopic dermatitis responds to peroxisome proliferator-activated receptors alpha and beta/delta (but not gamma) and liver X receptor activators
    • 160-9.e1-5
    • Hatano Y, Man MQ, Uchida Y, Crumrine D, Mauro TM, Feingold KR, Elias PM, Holleran WM. Murine atopic dermatitis responds to peroxisome proliferator-activated receptors alpha and beta/delta (but not gamma) and liver X receptor activators. J Allergy Clin Immunol 2010;125:160-9.e1-5.
    • (2010) J Allergy Clin Immunol , vol.125
    • Hatano, Y.1    Man, M.Q.2    Uchida, Y.3    Crumrine, D.4    Mauro, T.M.5    Feingold, K.R.6    Elias, P.M.7    Holleran, W.M.8
  • 45
    • 33947615887 scopus 로고    scopus 로고
    • Peroxisome proliferator- activated receptor gamma (PPARgamma) and immunoregulation: enhancement of regulatory T cells through PPARgamma-dependent and -independent mechanisms
    • Wohlfert EA, Nichols FC, Nevius E, Clark RB. Peroxisome proliferator- activated receptor gamma (PPARgamma) and immunoregulation: enhancement of regulatory T cells through PPARgamma-dependent and -independent mechanisms. J Immunol 2007;178:4129-35.
    • (2007) J Immunol , vol.178 , pp. 4129-4135
    • Wohlfert, E.A.1    Nichols, F.C.2    Nevius, E.3    Clark, R.B.4
  • 46
    • 84882286067 scopus 로고    scopus 로고
    • Expressions of peroxisome proliferator-activated receptors (PPARs) are directly influenced by permeability barrier abrogation and inflammatory cytokines and depressed PPARalpha modulates expressions of chemokines and epidermal differentiation-related molecules in keratinocytes
    • Adachi Y, Hatano Y, Sakai T, Fujiwara S. Expressions of peroxisome proliferator-activated receptors (PPARs) are directly influenced by permeability barrier abrogation and inflammatory cytokines and depressed PPARalpha modulates expressions of chemokines and epidermal differentiation-related molecules in keratinocytes. Exp Dermatol 2013;22:606-8.
    • (2013) Exp Dermatol , vol.22 , pp. 606-608
    • Adachi, Y.1    Hatano, Y.2    Sakai, T.3    Fujiwara, S.4
  • 48
    • 80051798789 scopus 로고    scopus 로고
    • Efficacy of combined peroxisome proliferator-activated receptor-alpha ligand and glucocorticoid therapy in a murine model of atopic dermatitis
    • Hatano Y, Elias PM, Crumrine D, Feingold KR, Katagiri K, Fujiwara S. Efficacy of combined peroxisome proliferator-activated receptor-alpha ligand and glucocorticoid therapy in a murine model of atopic dermatitis. J Invest Dermatol 2011;131:1845-52.
    • (2011) J Invest Dermatol , vol.131 , pp. 1845-1852
    • Hatano, Y.1    Elias, P.M.2    Crumrine, D.3    Feingold, K.R.4    Katagiri, K.5    Fujiwara, S.6
  • 50
    • 38549161215 scopus 로고    scopus 로고
    • A retrospective case series review of the peroxisome proliferator-activated receptor ligand rosiglitazone in the treatment of atopic dermatitis
    • Behshad R, Cooper KD, Korman NJ. A retrospective case series review of the peroxisome proliferator-activated receptor ligand rosiglitazone in the treatment of atopic dermatitis. Arch Dermatol 2008;144:84-8.
    • (2008) Arch Dermatol , vol.144 , pp. 84-88
    • Behshad, R.1    Cooper, K.D.2    Korman, N.J.3
  • 52
    • 84896701729 scopus 로고    scopus 로고
    • Lipid abnormalities and lipid-based repair strategies in atopic dermatitis
    • with the editorial assistance of Joan Wakefield
    • Elias PM; with the editorial assistance of Joan Wakefield. Lipid abnormalities and lipid-based repair strategies in atopic dermatitis. Biochim Biophys Acta 2014;1841:323-30.
    • (2014) Biochim Biophys Acta , vol.1841 , pp. 323-330
    • Elias, P.M.1
  • 53
    • 84872692919 scopus 로고    scopus 로고
    • Innate immune defense system of the skin
    • 32-8.e8-9
    • Afshar M, Gallo RL. Innate immune defense system of the skin. Vet Dermatol 2013;24:32-8.e8-9.
    • (2013) Vet Dermatol , vol.24
    • Afshar, M.1    Gallo, R.L.2
  • 55
    • 61349169039 scopus 로고    scopus 로고
    • AMPed up immunity: how antimicrobial peptides have multiple roles in immune defense
    • Lai Y, Gallo RL. AMPed up immunity: how antimicrobial peptides have multiple roles in immune defense. Trends Immunol 2009;30:131-41.
    • (2009) Trends Immunol , vol.30 , pp. 131-141
    • Lai, Y.1    Gallo, R.L.2
  • 60
    • 84883599387 scopus 로고    scopus 로고
    • Expression of antimicrobial peptides in atopic dermatitis and possible immunoregulatory functions
    • Kopfnagel V, Harder J, Werfel T. Expression of antimicrobial peptides in atopic dermatitis and possible immunoregulatory functions. Curr Opin Allergy Clin Immunol 2013;13:531-6.
    • (2013) Curr Opin Allergy Clin Immunol , vol.13 , pp. 531-536
    • Kopfnagel, V.1    Harder, J.2    Werfel, T.3
  • 62
    • 77954824600 scopus 로고    scopus 로고
    • Expression of antimicrobial peptides such as LL-37 and hBD-2 in nonlesional skin of atopic individuals
    • Goo J, Ji JH, Jeon H, Kim MJ, Jeon SY, Cho MY, Lee SH, Choi EH. Expression of antimicrobial peptides such as LL-37 and hBD-2 in nonlesional skin of atopic individuals. Pediatr Dermatol 2010;27:341-8.
    • (2010) Pediatr Dermatol , vol.27 , pp. 341-348
    • Goo, J.1    Ji, J.H.2    Jeon, H.3    Kim, M.J.4    Jeon, S.Y.5    Cho, M.Y.6    Lee, S.H.7    Choi, E.H.8
  • 64
    • 49749104216 scopus 로고    scopus 로고
    • Differential mRNA expression of antimicrobial peptides and proteins in atopic dermatitis as compared to psoriasis vulgaris and healthy skin
    • Gambichler T, Skrygan M, Tomi NS, Othlinghaus N, Brockmeyer NH, Altmeyer P, Kreuter A. Differential mRNA expression of antimicrobial peptides and proteins in atopic dermatitis as compared to psoriasis vulgaris and healthy skin. Int Arch Allergy Immunol 2008;147:17-24.
    • (2008) Int Arch Allergy Immunol , vol.147 , pp. 17-24
    • Gambichler, T.1    Skrygan, M.2    Tomi, N.S.3    Othlinghaus, N.4    Brockmeyer, N.H.5    Altmeyer, P.6    Kreuter, A.7
  • 65
    • 78650277281 scopus 로고    scopus 로고
    • Urocanic acid in the skin: a mixed blessing?
    • Gibbs NK, Norval M. Urocanic acid in the skin: a mixed blessing? J Invest Dermatol 2011;131:14-7.
    • (2011) J Invest Dermatol , vol.131 , pp. 14-17
    • Gibbs, N.K.1    Norval, M.2
  • 66
    • 84903445861 scopus 로고    scopus 로고
    • Photo(chemo)therapy in the management of atopic dermatitis: an updated systematic review with the use of GRADE and implications for practice and research
    • Forthcoming
    • Garritsen FM, Brouwer MW, Limpens J, Spuls PI. Photo(chemo)therapy in the management of atopic dermatitis: an updated systematic review with the use of GRADE and implications for practice and research. Br J Dermatol. Forthcoming 2013.
    • (2013) Br J Dermatol
    • Garritsen, F.M.1    Brouwer, M.W.2    Limpens, J.3    Spuls, P.I.4
  • 68
    • 57349167517 scopus 로고    scopus 로고
    • Biopositive effects of low-dose UVB on epidermis: coordinate upregulation of antimicrobial peptides and permeability barrier reinforcement
    • Hong SP, Kim MJ, Jung MY, Jeon H, Goo J, Ahn SK, Lee SH, Elias PM, Choi EH. Biopositive effects of low-dose UVB on epidermis: coordinate upregulation of antimicrobial peptides and permeability barrier reinforcement. J Invest Dermatol 2008;128:2880-7.
    • (2008) J Invest Dermatol , vol.128 , pp. 2880-2887
    • Hong, S.P.1    Kim, M.J.2    Jung, M.Y.3    Jeon, H.4    Goo, J.5    Ahn, S.K.6    Lee, S.H.7    Elias, P.M.8    Choi, E.H.9
  • 70
    • 47949099916 scopus 로고    scopus 로고
    • From endoplasmic-reticulum stress to the inflammatory response
    • Zhang K, Kaufman RJ. From endoplasmic-reticulum stress to the inflammatory response. Nature 2008;454:455-62.
    • (2008) Nature , vol.454 , pp. 455-462
    • Zhang, K.1    Kaufman, R.J.2
  • 71
    • 80053204171 scopus 로고    scopus 로고
    • Regulation of cathelicidin antimicrobial peptide expression by an endoplasmic reticulum (ER) stress signaling, vitamin D receptor-independent pathway
    • Park K, Elias PM, Oda Y, Mackenzie D, Mauro T, Holleran WM, Uchida Y. Regulation of cathelicidin antimicrobial peptide expression by an endoplasmic reticulum (ER) stress signaling, vitamin D receptor-independent pathway. J Biol Chem 2011;286:34121-30.
    • (2011) J Biol Chem , vol.286 , pp. 34121-34130
    • Park, K.1    Elias, P.M.2    Oda, Y.3    Mackenzie, D.4    Mauro, T.5    Holleran, W.M.6    Uchida, Y.7
  • 72
    • 84882248309 scopus 로고    scopus 로고
    • Ultraviolet radiation regulates cortisol activity in a waveband-dependent manner in human skin ex vivo
    • Skobowiat C, Sayre RM, Dowdy JC, Slominski AT. Ultraviolet radiation regulates cortisol activity in a waveband-dependent manner in human skin ex vivo. Br J Dermatol 2013;168:595-601.
    • (2013) Br J Dermatol , vol.168 , pp. 595-601
    • Skobowiat, C.1    Sayre, R.M.2    Dowdy, J.C.3    Slominski, A.T.4
  • 73
    • 84864001201 scopus 로고    scopus 로고
    • DC-derived TSLP promotes Th2 polarization in LPS-primed allergic airway inflammation
    • Zhang Y, Zhou X, Zhou B. DC-derived TSLP promotes Th2 polarization in LPS-primed allergic airway inflammation. Eur J Immunol 2012;42:1735-43.
    • (2012) Eur J Immunol , vol.42 , pp. 1735-1743
    • Zhang, Y.1    Zhou, X.2    Zhou, B.3
  • 75
    • 33746792458 scopus 로고    scopus 로고
    • Topical vitamin D3 and low-calcemic analogs induce thymic stromal lymphopoietin in mouse keratinocytes and trigger an atopic dermatitis
    • Li M, Hener P, Zhang Z, Kato S, Metzger D, Chambon P. Topical vitamin D3 and low-calcemic analogs induce thymic stromal lymphopoietin in mouse keratinocytes and trigger an atopic dermatitis. Proc Natl Acad Sci U S A 2006;103:11736-41.
    • (2006) Proc Natl Acad Sci U S A , vol.103 , pp. 11736-11741
    • Li, M.1    Hener, P.2    Zhang, Z.3    Kato, S.4    Metzger, D.5    Chambon, P.6
  • 78
    • 70249093313 scopus 로고    scopus 로고
    • Proteases induce production of thymic stromal lymphopoietin by airway epithelial cells through protease-activated receptor-2
    • Kouzaki H, O'Grady SM, Lawrence CB, Kita H. Proteases induce production of thymic stromal lymphopoietin by airway epithelial cells through protease-activated receptor-2. J Immunol 2009;183:1427-34.
    • (2009) J Immunol , vol.183 , pp. 1427-1434
    • Kouzaki, H.1    O'Grady, S.M.2    Lawrence, C.B.3    Kita, H.4
  • 81
    • 37049001821 scopus 로고    scopus 로고
    • Characterization of a hapten-induced, murine model with multiple features of atopic dermatitis: structural, immunologic, and biochemical changes following single versus multiple oxazolone challenges
    • Man MQ, Hatano Y, Lee SH, Man M, Chang S, Feingold KR, Leung DY, Holleran W, Uchida Y, Elias PM. Characterization of a hapten-induced, murine model with multiple features of atopic dermatitis: structural, immunologic, and biochemical changes following single versus multiple oxazolone challenges. J Invest Dermatol 2008;128:79-86.
    • (2008) J Invest Dermatol , vol.128 , pp. 79-86
    • Man, M.Q.1    Hatano, Y.2    Lee, S.H.3    Man, M.4    Chang, S.5    Feingold, K.R.6    Leung, D.Y.7    Holleran, W.8    Uchida, Y.9    Elias, P.M.10
  • 82
    • 84860625144 scopus 로고    scopus 로고
    • The effect of adipose-derived stem cell-cultured media on oxazolone treated atopic dermatitis- like murine model
    • Lee HJ, Jung M, Kim JH, Yoon NY, Choi EH. The effect of adipose-derived stem cell-cultured media on oxazolone treated atopic dermatitis- like murine model. Ann Dermatol 2012;24:181-8.
    • (2012) Ann Dermatol , vol.24 , pp. 181-188
    • Lee, H.J.1    Jung, M.2    Kim, J.H.3    Yoon, N.Y.4    Choi, E.H.5
  • 85
    • 0037083291 scopus 로고    scopus 로고
    • Development of atopic dermatitis-like skin lesions in STAT6-deficient NC/Nga mice
    • Yagi R, Nagai H, Iigo Y, Akimoto T, Arai T, Kubo M. Development of atopic dermatitis-like skin lesions in STAT6-deficient NC/Nga mice. J Immunol 2002;168:2020-7.
    • (2002) J Immunol , vol.168 , pp. 2020-2027
    • Yagi, R.1    Nagai, H.2    Iigo, Y.3    Akimoto, T.4    Arai, T.5    Kubo, M.6
  • 87
    • 84858317268 scopus 로고    scopus 로고
    • The Role of TSLP in IL-13-induced atopic march
    • Zhu Z, Oh MH, Yu J, Liu YJ, Zheng T. The Role of TSLP in IL-13-induced atopic march. Sci Rep 2011;1:23.
    • (2011) Sci Rep , vol.1 , pp. 23
    • Zhu, Z.1    Oh, M.H.2    Yu, J.3    Liu, Y.J.4    Zheng, T.5
  • 88
    • 66249095960 scopus 로고    scopus 로고
    • Skin-derived TSLP triggers progression from epidermal-barrier defects to asthma
    • Demehri S, Morimoto M, Holtzman MJ, Kopan R. Skin-derived TSLP triggers progression from epidermal-barrier defects to asthma. PLoS Biol 2009;7:e1000067.
    • (2009) PLoS Biol , vol.7
    • Demehri, S.1    Morimoto, M.2    Holtzman, M.J.3    Kopan, R.4
  • 89
    • 84856002592 scopus 로고    scopus 로고
    • Cutting edge: persistence of increased mast cell numbers in tissues links dermatitis to enhanced airway disease in a mouse model of atopy
    • Hershko AY, Charles N, Olivera A, Alvarez-Errico D, Rivera J. Cutting edge: persistence of increased mast cell numbers in tissues links dermatitis to enhanced airway disease in a mouse model of atopy. J Immunol 2012;188:531-5.
    • (2012) J Immunol , vol.188 , pp. 531-535
    • Hershko, A.Y.1    Charles, N.2    Olivera, A.3    Alvarez-Errico, D.4    Rivera, J.5
  • 90
    • 84874889571 scopus 로고    scopus 로고
    • Barrier-restoring therapies in atopic dermatitis: current approaches and future perspectives
    • Valdman-Grinshpoun Y, Ben-Amitai D, Zvulunov A. Barrier-restoring therapies in atopic dermatitis: current approaches and future perspectives. Dermatol Res Pract 2012;2012:923134.
    • (2012) Dermatol Res Pract , vol.2012 , pp. 923134
    • Valdman-Grinshpoun, Y.1    Ben-Amitai, D.2    Zvulunov, A.3
  • 93
    • 84886036219 scopus 로고    scopus 로고
    • Barrier-repair prescription moisturizers: do we really need them? Facts and controversies
    • Wolf R, Parish LC. Barrier-repair prescription moisturizers: do we really need them? Facts and controversies. Clin Dermatol 2013;31:787-91.
    • (2013) Clin Dermatol , vol.31 , pp. 787-791
    • Wolf, R.1    Parish, L.C.2
  • 95
    • 84855873391 scopus 로고    scopus 로고
    • Nonsteroidal treatment of atopic dermatitis in pediatric patients with a ceramide-dominant topical emulsion formulated with an optimized ratio of physiological lipids
    • Kircik LH, Del Rosso JQ. Nonsteroidal treatment of atopic dermatitis in pediatric patients with a ceramide-dominant topical emulsion formulated with an optimized ratio of physiological lipids. J Clin Aesthet Dermatol 2011;4:25-31.
    • (2011) J Clin Aesthet Dermatol , vol.4 , pp. 25-31
    • Kircik, L.H.1    Del Rosso, J.Q.2
  • 96
    • 74049086065 scopus 로고    scopus 로고
    • Efficacy of a lipid-based barrier repair formulation in moderate-to-severe pediatric atopic dermatitis
    • Sugarman JL, Parish LC. Efficacy of a lipid-based barrier repair formulation in moderate-to-severe pediatric atopic dermatitis. J Drugs Dermatol 2009;8:1106-11.
    • (2009) J Drugs Dermatol , vol.8 , pp. 1106-1111
    • Sugarman, J.L.1    Parish, L.C.2
  • 97
    • 79953180580 scopus 로고    scopus 로고
    • Pseudoceramide- containing physiological lipid mixture reduces adverse effects of topical steroids
    • Kim HJ, Park HJ, Yun JN, Jeong SK, Ahn SK, Lee SH. Pseudoceramide- containing physiological lipid mixture reduces adverse effects of topical steroids. Allergy Asthma Immunol Res 2011;3:96-102.
    • (2011) Allergy Asthma Immunol Res , vol.3 , pp. 96-102
    • Kim, H.J.1    Park, H.J.2    Yun, J.N.3    Jeong, S.K.4    Ahn, S.K.5    Lee, S.H.6
  • 98
    • 0141887511 scopus 로고    scopus 로고
    • The characterization of molecular organization of multilamellar emulsions containing pseudoceramide and type III synthetic ceramide
    • Park BD, Youm JK, Jeong SK, Choi EH, Ahn SK, Lee SH. The characterization of molecular organization of multilamellar emulsions containing pseudoceramide and type III synthetic ceramide. J Invest Dermatol 2003;121:794-801.
    • (2003) J Invest Dermatol , vol.121 , pp. 794-801
    • Park, B.D.1    Youm, J.K.2    Jeong, S.K.3    Choi, E.H.4    Ahn, S.K.5    Lee, S.H.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.